1. Altamirano-Barrera A, Barranco-Fragoso B, Méndez-Sánchez N, ‘Management strategies for liver fibrosis’, Ann Hepatol, 16(1), 48–56.
2. Chen LH, Hsu CY, Weng CF, ‘Involvement of P53 and Bax/Bad triggering apoptosis in thioacetamide-induced hepatic epithelial cells’, World J Gastroenterol, 28;12(32), 5175–81.
3. Choi EH, Lee DY, Kim S, Chung JO, Choi JK, Joo KM, Jeong HW, Kim JK, Kim WG, Shim SM, ‘Influence of flavonol-rich excipient food (onion peel and Dendropanax morbifera) on the bioavailability of green tea epicatechins in vitro and in vivo’, Food Funct. 8(10), 3664–3674.
4. Clichici S, Olteanu D, Nagy AL, Oros A, Filip A, Mircea PA, ‘Silymarin inhibits the progression of fibrosis in the early stages of liver injury in CCl4-treated rats’, J. Med. Food, 18, 290–298.
5. De Minicis S, Marzioni M, Saccomanno S, Rychlicki C, Agostinelli L, Trozzi L, Benedetti A, Svegliati-Baroni G, ‘Cellular and molecular mechanisms of hepatic fibrogenesis leading to liver cancer’, Transl. Gastrointest. Cancer, 1, 88–94.